Gottlieb Calls For Changes To Senate-Passed Right To Try Bill

FDA Commissioner Scott Gottlieb urged lawmakers Tuesday (Oct. 3) to revamp the Senate-passed Right to Try legislation now pending in the lower chamber by narrowing the patient population covered, further restricting promotion and commercialization of the experimental drugs, ensuring FDA's authority to take certain enforcement actions and protecting FDA from federal tort liability. Gottlieb outlined FDA's concerns at a House Energy & Commerce subcommittee hearing held two months after the Senate passed an amended version of Sen. Ron Johnson's (R-WI)...